Cargando…

Metformin combined with endoscopic therapy in patients with familial polyposis associated with carcinoma: A case report

Familial adenomatous polyposis (FAP) is an autosomal dominant genetic disease, with a very high cancer rate. At present, endoscopic resection of polyps ≥ 1 cm is often chosen for patients with non-cancerous polyps who are unwilling to undergo surgery, and regular review is conducted. Once the polyps...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Dong-Jie, He, Xiao-Jian, Li, Hai-Tao, Luo, Bao-Xiang, Zhou, Lin-Xin, Zeng, Xiang-Peng, Li, Da-Zhou, Wang, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794309/
https://www.ncbi.nlm.nih.gov/pubmed/36595813
http://dx.doi.org/10.1097/MD.0000000000032408
_version_ 1784860010406215680
author Sun, Dong-Jie
He, Xiao-Jian
Li, Hai-Tao
Luo, Bao-Xiang
Zhou, Lin-Xin
Zeng, Xiang-Peng
Li, Da-Zhou
Wang, Wen
author_facet Sun, Dong-Jie
He, Xiao-Jian
Li, Hai-Tao
Luo, Bao-Xiang
Zhou, Lin-Xin
Zeng, Xiang-Peng
Li, Da-Zhou
Wang, Wen
author_sort Sun, Dong-Jie
collection PubMed
description Familial adenomatous polyposis (FAP) is an autosomal dominant genetic disease, with a very high cancer rate. At present, endoscopic resection of polyps ≥ 1 cm is often chosen for patients with non-cancerous polyps who are unwilling to undergo surgery, and regular review is conducted. Once the polyps are pathologically confirmed to be cancerous, surgical resection of the diseased large intestine is generally recommended, but surgery often leads to a series of complications. So what do you do with cancer patients who don’t want surgery? PATIENT CONCERNS: A 19-year-old woman presented with intermittent hematochezia with abdominal pain. A colonoscopy revealed hundreds of intestinal polyps. DIAGNOSES: The patient had a family history of FAP, and there were hundreds of polyps in the intestine. The pathology was adenomatous, and some polyps became cancerous, which met the diagnostic criteria of FAP. INTERVENTIONS: Endoscopic examination was arranged for the patient, the resection of intestinal polyps ≥ 1 cm was given priority, and other polyps were removed as far as possible. After that, metformin 500 mg orally was given twice a day, and endoscopic follow-up was conducted every 6 months. During each endoscopic follow-up, intestinal polyps ≥ 1 cm were preferred to be removed, and other polyps were removed as far as possible. OUTCOMES: The patient’s abdominal pain and blood in the stool disappeared after endoscopic treatment. Cancerous polyps were found at the second and third follow-up visits, but the patient always refused surgical treatment. After 4 years of follow-up, polyp load was significantly reduced, abdominal pain and bloody stool symptoms did not appear again, and imaging examination showed no tumor recurrence and metastasis. LESSONS: Endoscopic polyp resection is an important method to treat the clinical symptoms of FAP. Metformin combined with endoscopic therapy is a good alternative for patients with familial polyposis who do not want surgery. When the polyp is cancerous and the polyp is radically resected by the endoscope, if the patient refuses additional surgery, oral metformin combined with endoscopic follow-up can be considered.
format Online
Article
Text
id pubmed-9794309
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-97943092022-12-28 Metformin combined with endoscopic therapy in patients with familial polyposis associated with carcinoma: A case report Sun, Dong-Jie He, Xiao-Jian Li, Hai-Tao Luo, Bao-Xiang Zhou, Lin-Xin Zeng, Xiang-Peng Li, Da-Zhou Wang, Wen Medicine (Baltimore) 4500 Familial adenomatous polyposis (FAP) is an autosomal dominant genetic disease, with a very high cancer rate. At present, endoscopic resection of polyps ≥ 1 cm is often chosen for patients with non-cancerous polyps who are unwilling to undergo surgery, and regular review is conducted. Once the polyps are pathologically confirmed to be cancerous, surgical resection of the diseased large intestine is generally recommended, but surgery often leads to a series of complications. So what do you do with cancer patients who don’t want surgery? PATIENT CONCERNS: A 19-year-old woman presented with intermittent hematochezia with abdominal pain. A colonoscopy revealed hundreds of intestinal polyps. DIAGNOSES: The patient had a family history of FAP, and there were hundreds of polyps in the intestine. The pathology was adenomatous, and some polyps became cancerous, which met the diagnostic criteria of FAP. INTERVENTIONS: Endoscopic examination was arranged for the patient, the resection of intestinal polyps ≥ 1 cm was given priority, and other polyps were removed as far as possible. After that, metformin 500 mg orally was given twice a day, and endoscopic follow-up was conducted every 6 months. During each endoscopic follow-up, intestinal polyps ≥ 1 cm were preferred to be removed, and other polyps were removed as far as possible. OUTCOMES: The patient’s abdominal pain and blood in the stool disappeared after endoscopic treatment. Cancerous polyps were found at the second and third follow-up visits, but the patient always refused surgical treatment. After 4 years of follow-up, polyp load was significantly reduced, abdominal pain and bloody stool symptoms did not appear again, and imaging examination showed no tumor recurrence and metastasis. LESSONS: Endoscopic polyp resection is an important method to treat the clinical symptoms of FAP. Metformin combined with endoscopic therapy is a good alternative for patients with familial polyposis who do not want surgery. When the polyp is cancerous and the polyp is radically resected by the endoscope, if the patient refuses additional surgery, oral metformin combined with endoscopic follow-up can be considered. Lippincott Williams & Wilkins 2022-12-23 /pmc/articles/PMC9794309/ /pubmed/36595813 http://dx.doi.org/10.1097/MD.0000000000032408 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle 4500
Sun, Dong-Jie
He, Xiao-Jian
Li, Hai-Tao
Luo, Bao-Xiang
Zhou, Lin-Xin
Zeng, Xiang-Peng
Li, Da-Zhou
Wang, Wen
Metformin combined with endoscopic therapy in patients with familial polyposis associated with carcinoma: A case report
title Metformin combined with endoscopic therapy in patients with familial polyposis associated with carcinoma: A case report
title_full Metformin combined with endoscopic therapy in patients with familial polyposis associated with carcinoma: A case report
title_fullStr Metformin combined with endoscopic therapy in patients with familial polyposis associated with carcinoma: A case report
title_full_unstemmed Metformin combined with endoscopic therapy in patients with familial polyposis associated with carcinoma: A case report
title_short Metformin combined with endoscopic therapy in patients with familial polyposis associated with carcinoma: A case report
title_sort metformin combined with endoscopic therapy in patients with familial polyposis associated with carcinoma: a case report
topic 4500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794309/
https://www.ncbi.nlm.nih.gov/pubmed/36595813
http://dx.doi.org/10.1097/MD.0000000000032408
work_keys_str_mv AT sundongjie metformincombinedwithendoscopictherapyinpatientswithfamilialpolyposisassociatedwithcarcinomaacasereport
AT hexiaojian metformincombinedwithendoscopictherapyinpatientswithfamilialpolyposisassociatedwithcarcinomaacasereport
AT lihaitao metformincombinedwithendoscopictherapyinpatientswithfamilialpolyposisassociatedwithcarcinomaacasereport
AT luobaoxiang metformincombinedwithendoscopictherapyinpatientswithfamilialpolyposisassociatedwithcarcinomaacasereport
AT zhoulinxin metformincombinedwithendoscopictherapyinpatientswithfamilialpolyposisassociatedwithcarcinomaacasereport
AT zengxiangpeng metformincombinedwithendoscopictherapyinpatientswithfamilialpolyposisassociatedwithcarcinomaacasereport
AT lidazhou metformincombinedwithendoscopictherapyinpatientswithfamilialpolyposisassociatedwithcarcinomaacasereport
AT wangwen metformincombinedwithendoscopictherapyinpatientswithfamilialpolyposisassociatedwithcarcinomaacasereport